Home › Funds › Legato Capital Management LLC › RGEN

Legato Capital Management LLC position in RGEN

Repligen Corp · Health Care

Legato Capital Management LLC reported holding 30,739 shares of RGEN (Repligen Corp) in its Q3 2026 13F filing — a position valued at US$5.9M, representing 0.57% of its reported portfolio and ranking #21 among its reported holdings. Legato Capital Management LLC has disclosed RGEN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)30.74K sh
Reported value held$5.91M
Portfolio Weight0.57%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Legato Capital Management LLC's RGEN position evolved

Legato Capital Management LLC first disclosed a stake in RGEN in Q3 2023 at 6,700 shares (US$1.1M). The position peaked in Q3 2026 at 30,739 shares, worth US$5.9M. Across 13 filings, Legato Capital Management LLC increased the stake 5 time(s), trimmed it 4 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 30,739 shares valued at US$5.9M — an increase of 16,177 shares quarter over quarter.. Notable position changes include a 46% increase in Q3 2024 (shares fell 3% over the following quarter), a 102% increase in Q1 2025 (shares fell 2% over the following quarter), a 111% increase in Q3 2026 (shares fell 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 6.70K $1.07M New
Q4 2023 6.70K $1.20M Hold
Q1 2024 6.70K $1.23M Hold
Q2 2024 7.94K $1.00M Add
Q3 2024 11.57K $1.72M Add
Q4 2024 7.94K $1.14M Reduce
Q1 2025 16.00K $2.04M Add
Q2 2025 16.00K $1.99M Hold
Q3 2025 21.10K $2.82M Add
Q4 2025 20.16K $3.30M Reduce
Q1 2026 16.50K $1.94M Reduce
Q2 2026 14.56K $1.99M Reduce
Q3 2026 30.74K $5.91M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RGEN and 13F data

RGEN (Repligen Corp) is a Health Care company. 33 other funds we track also report a position in RGEN — the largest reported positions include UNITED CAPITAL FINANCIAL ADVISORS, LLC (US$536.3M), Maverick Capital (US$270.8M), MAVERICK CAPITAL LTD (US$270.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RGEN

All RGEN fund holders →

FAQ

How long has Legato Capital Management LLC held RGEN?

Legato Capital Management LLC has disclosed RGEN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Legato Capital Management LLC's current position in RGEN?

As of Q3 2026, Legato Capital Management LLC holds 30.74K shares of RGEN (Repligen Corp), valued at $5.91M, representing 0.57% of its reported portfolio and ranking #21.

Has Legato Capital Management LLC been buying or selling RGEN?

In the latest 13F filing (Q3 2026), Legato Capital Management LLC increased its position in RGEN. The position peaked in Q3 2026 at 30.74K shares.

Which other funds hold RGEN?

Other major institutional holders of RGEN include UNITED CAPITAL FINANCIAL ADVISORS, LLC, Maverick Capital, MAVERICK CAPITAL LTD, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.